Thomas M. Broderick

Regional Wall Motion Index for Infarct and Noninfarct Regions after Reperfusion in Acute Myocardial Infarction: Comparison With Global Wall Motion Index

Patrick D.V. Bourdillon, Thomas M. Broderick, Stephen G. Sawada et al. · Journal of the American Society of Echocardiography · 1989 · 157 citations

Thrombosis, Heart Failure, Cardiovascular Disease +12

Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention.

Kereiakes Dj, Cindy L. Grines, E Fry et al. · PubMed · 2001 · 143 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +14

Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management

Eric J. Dippel, Dean J. Kereiakes, Daniel A. Tramuta et al. · Catheterization and Cardiovascular Interventions · 2001 · 135 citations

Heart Failure, Coronary Artery Perforation, Coronary Artery Disease +22

Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial

Gregg W. Stone, Stephen G. Ellis, Tommaso Gori et al. · The Lancet · 2018 · 135 citations

Cardiovascular Disease, Myocardial Infarction, Outcomes Research +9

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

Dean J. Kereiakes, Thomas M. Broderick, Eli M. Roth et al. · The American Journal of Cardiology · 1999 · 134 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +10